Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population

BACKGROUND: Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among patients with non-valvular atrial fibrillation (NVAF), but the comparative risk of major bleeding varies between DOA...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Kiran, Trocio, Jeffrey, Keshishian, Allison, Zhang, Qisu, Dina, Oluwaseyi, Mardekian, Jack, Nadkarni, Anagha, Shank, Thomas C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567643/
https://www.ncbi.nlm.nih.gov/pubmed/31195999
http://dx.doi.org/10.1186/s12872-019-1116-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567643/
https://www.ncbi.nlm.nih.gov/pubmed/31195999
http://dx.doi.org/10.1186/s12872-019-1116-1

Ejemplares similares